Primary hyperoxaluria type 2

Explore clinical trials studying Primary hyperoxaluria type 2. Study availability and eligibility vary by location and protocol.

8 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Primary hyperoxaluria type 2 trial results

Recruiting

NCT02026388

Conditions: APRT Deficiency, Adenine phosphoribosyltransferase deficiency, Carbohydrate Metabolism, Inborn Errors, +21 more
Locations: Mayo Clinic Rochester, Minnesota, United States

Recruiting

NCT07681271

Conditions: Papulopustular Rosacea, Primary hyperoxaluria type 2, Rosacea, +2 more
Locations: Three A Research El Paso, Texas, United States

Not Yet Recruiting

NCT06465472

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +16 more
Locations: Not specified

Completed

NCT05001269

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +17 more
Locations: Clinical Research Site Rochester, Minnesota, United States

Clinical Research Site Hamilton, Ontario, Canada

Clinical Trial Site Bonn, Germany

Clinical Research Site Heidelberg, Germany

View all 13 locations

Completed

NCT03847909

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +16 more
Locations: Clinical Trial Site San Francisco, California, United States

Clinical Trial Site Boston, Massachusetts, United States

Clinical Trial Site Rochester, Minnesota, United States

Clinical Trial Site New York, United States

View all 28 locations

Completed

NCT00254540

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Pfizer Investigational Site Akita, Japan

Pfizer Investigational Site Sapporo, Hokkaido, Japan

Pfizer Investigational Site Tsukuba, Ibaragi, Japan

Pfizer Investigational Site Osaka, Japan

Active, Not Recruiting

NCT03655223

Conditions: 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations: RTI International Research Triangle Park, North Carolina, United States

Active, Not Recruiting

NCT04042402

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +17 more
Locations: Clinical Research Site San Francisco, California, United States

Clinical Trial Site Boston, Massachusetts, United States

Clinical Trial Site Rochester, Minnesota, United States

Clinical Trial Site New York, United States

View all 23 locations